Rupee Stuck Between Flows, Intervention Risk

Indian CurrencyMumbai: The Indian currency was jammed today between prospects that outsi

Taliban denies release of 30 Pak soldiers

Peshawar, Oct 15 : The Pakistani Taliban has denied that they have released 30 abducted army personnel in South Waziristan near the Afghan border on October 13.

3i Infotech Buys J&B Software & Its Arms For $25.25 Mn

3i Infotech Ltd3i Infotech has declared that it has signed an agreement to get hold of J&B So

Bill Clinton’s postcard to granny comes back to haunt him

Chilli peppers may help reduce acute post-surgery pain

Washington, Oct 15 : A new study has revealed that purified capsaicin, a drug derived from chilli peppers, may reduce acute post-surgery pain.

Why some people are allergic to fish and milk

Pages

News in Focus

Shriram Finance Share Price Target at Rs 1,200: ICICI Securities

ICICI Securities has maintained a BUY rating on Shriram Finance (SHRTRA) with a target price of Rs 1,200, implying an upside of ~19% from the current market price of Rs 1,011.

Crypto instead of Rupees: India’s Real-money Online Gaming ban boosts USDT demand and offshore Casino Growth

Since October 1, 2025, a nationwide ban on real-money online gaming has been in effect in India.

Sunteck Realty Share Price Target at Rs 520: Prabhudas Lilladher Stock Research

Sunteck Realty has delivered a robust operational and financial performance in FY26, reinforcing its positioning as a premium real estate developer in the Mumbai Metropolitan Region.

Cipla Share Price Target at Rs 1,550: ICICI Securities

ICICI Securities has upgraded Cipla to a BUY rating with a revised target price of Rs 1,550, implying a potential upside of nearly 19% from the current market price of Rs 1,306.

Tata Communications Share Price Target at Rs 2,100: ICICI Securities

ICICI Securities has reiterated its BUY call on Tata Communications, setting a revised target price of Rs 2,100, implying an upside potential of nearly 38% from the current market price of Rs 1,525

Infosys Share Price Target at Rs 1,497: Deven Choksey Research

Infosys, backed by a BUY recommendation from Deven Choksey Research, is entering a decisive phase where artificial intelligence moves from experimentation to real-world monetization.